FDA Approves New Version of PrEP—Just Two Shots A Year
The FDA has approved lenacapavir as a form of pre-exposure prophylaxis (PrEP), offering a new option for HIV prevention requiring only two shots per year.
PrEP
PrEP stands for pre-exposure prophylaxis. The word prophylaxis means to prevent or control the spread of an infection or disease. The goal of PrEP is to prevent HIV infection from taking hold if you are exposed to the virus.
Two Studies Show Doxy PEP is a Winning Strategy
Two studies published in this month’s JAMA Internal Medicine offer encouraging findings about the use of Doxy PEP.
Update to PrEP Recommendations Include Long-Acting Shot
The USPSTF recently released updated recommendations on Pre-Exposure Prophylaxis for preventing the sexual transmission of HIV. The recommendations add additional medications, including a long-acting injectable.
